Article info
PDFHow to understand it
Vision loss in giant cell arteritis
- Correspondence to Dr Edward Margolin, Department of Ophthalmology and Vision Science, University of Toronto, Toronto, Canada; Edward.margolin{at}uhn.ca
Citation
Vision loss in giant cell arteritis
Publication history
- Accepted June 15, 2021
- First published July 8, 2021.
Online issue publication
March 18, 2022
Article Versions
- Previous version (18 March 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Optical coherence tomographic angiography identifies peripapillary microvascular dilation and focal non-perfusion in giant cell arteritis
- Four common diseases causing sudden blindness or death in the eye emergency department
- The swollen optic nerve: an approach to diagnosis and management
- Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study
- Rapid visual recovery following intravenous tocilizumab in glucocorticoid resistant refractory giant cell arteritis
- Loss of vision
- Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy
- Fluorescein and indocyanine green angiography in arteritic anterior ischaemic optic neuropathy
- Diagnosis and management of giant cell arteritis and polymyalgia rheumatica: challenges, controversies and practical tips
- Non-arteritic anterior ischaemic optic neuropathy secondary to menorrhagia in a young healthy woman